Eculizumab

Results: 59



#Item
21Healthcare in Australia / Eculizumab / Immunosuppressants / Hemolytic-uremic syndrome / Pharmaceutical Benefits Scheme / Medicare / Dialysis / Medical prescription / Medicine / Health / Nephrology

Atypical Haemolytic Uraemic Syndrome (aHUS) - eculizumab - Continuing PBS authority application

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2015-03-05 22:46:33
22Renal physiology / Acquired hemolytic anemia / Hemolytic-uremic syndrome / Nephrology / Syndromes / Eculizumab / Thrombocytopenia / Renal function / Creatinine / Medicine / Biology / Health

Atypical Haemolytic Uraemic Syndrome (aHUS) – eculizumab Initial PBS authority application

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2015-03-09 19:12:48
23Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefi

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:51:53
24Pharmacology / Immunosuppressants / Orphan drugs / Medicine / Health / Eculizumab / Pharmaceuticals policy / Healthcare in Australia / Pharmaceutical Benefits Scheme

____________________________________________________________________ Pharmaceutical Benefits Advisory Committee ____________________________________________________________________ 19 September 2014

Add to Reading List

Source URL: www.health.gov.au

Language: English - Date: 2015-03-17 09:36:34
25Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:51:53
26Angiogenesis inhibitors / Benzazepines / Ivabradine / Lactams / Servier / Eculizumab / Bevacizumab / Olmesartan / Vandetanib / Chemistry / Organic chemistry / Orphan drugs

Microsoft Word - DAC_2014Q1_meeting_outcome_Eng.docx

Add to Reading List

Source URL: www.ha.org.hk

Language: English
27Biology / Meningococcal disease / Meningococcal vaccine / Eculizumab / Asplenia / Vaccination schedule / Conjugate vaccine / Vaccination / NmVac4-A/C/Y/W-135 / Vaccines / Medicine / Health

ACIP Res: No[removed]Vaccines to Prevent Meningococcal Disease

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2015-03-02 15:51:14
28Immune system / Immunology / Zinc finger nuclease / RNA interference / Monoclonal antibodies / Eculizumab / Small interfering RNA / Acute myeloid leukemia / Bispecific monoclonal antibody / Biology / RNA / Biotechnology

//fs/sites2/nbt_www/nbt_files[removed][removed]18552_4_fig_3_jdmpvg_fig.pdf

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-07-19 16:33:00
29Hematopathology / Complement system / Acquired hemolytic anemia / Eculizumab / Immunosuppressants / Paroxysmal nocturnal hemoglobinuria / Alexion Pharmaceuticals / Hemolytic anemia / Glycophosphatidylinositol / Medicine / Biology / Anatomy

NBT-RFV17092B Dr. Rother’s Figure 1 in PPT format_Rother1 25.ppt [Read-Only]

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-07-19 16:33:19
30Biology / Alternative complement pathway / Eculizumab / Complement control protein / Complement component 3 / C5-convertase / Complement component 5a / C3-convertase / C1-inhibitor / Complement system / Anatomy / Immune system

© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-07-19 16:33:18
UPDATE